Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.40 -0.05 (-11.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Revenue (2021 - 2022)

Updated

Pasithea Therapeutics (KTTA) reported Revenue of $240,712 for Q4 2022, up 10.1% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Revenue (2021 - 2022) Analysis & Trends

For FY2022, Pasithea Therapeutics posted Revenue of $486,559.

  • By year, Revenue came in at $15,062 in FY2021.
  • Per Business Quant data, the three quarters before Q4 2022 came in at $218,608 (Q3 2022), $13,581 (Q2 2022) and $13,658 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 25.40 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 16.99 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 15.03 Bn
10 Pasithea Therapeutics 13.37 Mn -142.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 240,712.00
Sep 30, 2022 218,608.00
Jun 30, 2022 13,581.00
Mar 31, 2022 13,658.00
Sep 30, 2021 -508.00
API Access

Pasithea Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KTTA&period=max&api_key=YOUR_API_KEY